- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Pharmaceutical Contract Development and Manufacturing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Pharmaceutical Contract Development and Manufacturing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Pharmaceutical Contract Development and Manufacturing market by product type, application, key companies and key regions.
This study considers the Pharmaceutical Contract Development and Manufacturing value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Pharmaceutical Manufacturing Services
Biologics Manufacturing Services
Drug Development Services
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Big Pharma
Small Pharma
Generic Pharma
CRO
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Recipharm AB
Almac Group
Catalent, Inc.
Thermo Fisher Scientific Inc.
Vetter Pharma International GMBH
Lonza Group Ltd
Aenova Group
FAMAR Health Care Services
Consort Medical plc
AbbVie Inc.
Siegfried Holding AG
Evonik Industries AG
Boehringer Ingelheim International GmbH
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Pharmaceutical Contract Development and Manufacturing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pharmaceutical Contract Development and Manufacturing market by identifying its various subsegments.
Focuses on the key global Pharmaceutical Contract Development and Manufacturing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pharmaceutical Contract Development and Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Pharmaceutical Contract Development and Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
Global Pharmaceutical Contract Development and Manufacturing Market Growth (Status and Outlook) 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Contract Development and Manufacturing Market Size 2014-2024
2.1.2 Pharmaceutical Contract Development and Manufacturing Market Size CAGR by Region
2.2 Pharmaceutical Contract Development and Manufacturing Segment by Type
2.2.1 Pharmaceutical Manufacturing Services
2.2.2 Pharmaceutical Manufacturing Services
2.2.3 Drug Development Services
2.3 Pharmaceutical Contract Development and Manufacturing Market Size by Type
2.3.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Type (2014-2019)
2.3.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (2014-2019)
2.4 Pharmaceutical Contract Development and Manufacturing Segment by Application
2.4.1 Big Pharma
2.4.2 Small Pharma
2.4.3 Generic Pharma
2.4.4 CRO
2.5 Pharmaceutical Contract Development and Manufacturing Market Size by Application
2.5.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Application (2014-2019)
2.5.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Application (2014-2019)
3 Global Pharmaceutical Contract Development and Manufacturing by Players
3.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Players
3.1.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Players (2017-2019)
3.1.2 Global Pharmaceutical Contract Development and Manufacturing Market Size Market Share by Players (2017-2019)
3.2 Global Pharmaceutical Contract Development and Manufacturing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmaceutical Contract Development and Manufacturing by Regions
4.1 Pharmaceutical Contract Development and Manufacturing Market Size by Regions
4.2 Americas Pharmaceutical Contract Development and Manufacturing Market Size Growth
4.3 APAC Pharmaceutical Contract Development and Manufacturing Market Size Growth
4.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size Growth
4.5 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Growth
5 Americas
5.1 Americas Pharmaceutical Contract Development and Manufacturing Market Size by Countries
5.2 Americas Pharmaceutical Contract Development and Manufacturing Market Size by Type
5.3 Americas Pharmaceutical Contract Development and Manufacturing Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Pharmaceutical Contract Development and Manufacturing Market Size by Countries
6.2 APAC Pharmaceutical Contract Development and Manufacturing Market Size by Type
6.3 APAC Pharmaceutical Contract Development and Manufacturing Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing by Countries
7.2 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Type
7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing by Countries
8.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Type
8.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Pharmaceutical Contract Development and Manufacturing Market Forecast
10.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Forecast (2019-2024)
10.2 Global Pharmaceutical Contract Development and Manufacturing Forecast by Regions
10.2.1 Global Pharmaceutical Contract Development and Manufacturing Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Pharmaceutical Contract Development and Manufacturing Forecast by Type
10.8 Global Pharmaceutical Contract Development and Manufacturing Forecast by Application
11 Key Players Analysis
11.1 Recipharm AB
11.1.1 Company Details
11.1.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.1.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Recipharm AB News
11.2 Almac Group
11.2.1 Company Details
11.2.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.2.3 Almac Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Almac Group News
11.3 Catalent, Inc.
11.3.1 Company Details
11.3.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.3.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Catalent, Inc. News
11.4 Thermo Fisher Scientific Inc.
11.4.1 Company Details
11.4.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.4.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. News
11.5 Vetter Pharma International GMBH
11.5.1 Company Details
11.5.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Vetter Pharma International GMBH News
11.6 Lonza Group Ltd
11.6.1 Company Details
11.6.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.6.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Lonza Group Ltd News
11.7 Aenova Group
11.7.1 Company Details
11.7.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.7.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Aenova Group News
11.8 FAMAR Health Care Services
11.8.1 Company Details
11.8.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.8.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 FAMAR Health Care Services News
11.9 Consort Medical plc
11.9.1 Company Details
11.9.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Consort Medical plc News
11.10 AbbVie Inc.
11.10.1 Company Details
11.10.2 Pharmaceutical Contract Development and Manufacturing Product Offered
11.10.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 AbbVie Inc. News
11.11 Siegfried Holding AG
11.12 Evonik Industries AG
11.13 Boehringer Ingelheim International GmbH
12 Research Findings and Conclusion
List of Tables and Figures
Table Product Specifications of Pharmaceutical Contract Development and Manufacturing
Figure Pharmaceutical Contract Development and Manufacturing Report Years Considered
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
